28072457|t|Effects of Binge-Like Ethanol Exposure During Adolescence on the Febrile Response in Rats
28072457|a|Ethanol (EtOH) exposure during different phases of life may increase the risk of infections and cause alterations in the central nervous system. The present study investigated the effects of binge-like EtOH exposure in adolescent rats on the febrile response that was induced by lipopolysaccharide (LPS) and interleukin-1β (IL-1β). Male rats were exposed to EtOH from postnatal days 25 to 38 in a binge-like pattern. Fever was induced by LPS (5 and 50 μg/kg, intraperitoneally) and evaluated on postnatal days 51 and 63, or by IL-β (3 ng) and evaluated on postnatal day 51. Hematological parameters, the status of peritoneal macrophages, and plasma and cerebrospinal IL-1β levels were also evaluated on postnatal day 51. EtOH exposure during adolescence did not alter normal body temperature. However, a significant reduction in the febrile response that was induced by LPS at both doses was observed on postnatal day 51. However, no changes in the febrile response were observed on postnatal day 63 in EtOH-exposed animals. The febrile response that was induced by intracerebroventricular IL-1β also significantly decreased in animals that received binge-like EtOH exposure during adolescence. Acute oral treatment with EtOH 24 h prior to LPS administration did not alter the febrile response that was induced by LPS. Binge-like EtOH exposure during adolescence did not alter hematological parameters or the number or viability of peritoneal macrophages. Binge-like EtOH exposure did not alter plasma IL-1β levels but reduced the cerebrospinal fluid levels of this cytokine. These results suggest that binge-like EtOH exposure during adolescence causes changes in the central nervous system that can impair the febrile response that can be observed after the cessation of EtOH exposure. These changes were reversible and appeared to involve the LPS / IL-1β system.
28072457	11	21	Binge-Like	T055	C0556346
28072457	22	38	Ethanol Exposure	UnknownType	C0814017
28072457	46	57	Adolescence	T079	C0001578
28072457	65	72	Febrile	T184	C0015967
28072457	73	81	Response	T032	C0871261
28072457	85	89	Rats	T015	C0034721
28072457	90	113	Ethanol (EtOH) exposure	UnknownType	C0814017
28072457	131	137	phases	T079	C0205390
28072457	141	145	life	T078	C0376558
28072457	163	181	risk of infections	T033	C0582147
28072457	192	203	alterations	T078	C1515926
28072457	211	233	central nervous system	T022	C3714787
28072457	281	291	binge-like	T055	C0556346
28072457	292	305	EtOH exposure	UnknownType	C0814017
28072457	309	319	adolescent	T079	C0001578
28072457	320	324	rats	T015	C0034721
28072457	332	339	febrile	T184	C0015967
28072457	340	348	response	T032	C0871261
28072457	369	387	lipopolysaccharide	T109	C0023810
28072457	389	392	LPS	T109	C0023810
28072457	398	412	interleukin-1β	T116,T129	C0021753
28072457	414	419	IL-1β	T116,T129	C0021753
28072457	427	431	rats	T015	C0034721
28072457	437	452	exposed to EtOH	UnknownType	C0814017
28072457	458	472	postnatal days	T079	C0443281
28072457	487	497	binge-like	T055	C0556346
28072457	507	512	Fever	T184	C0015967
28072457	528	531	LPS	T109	C0023810
28072457	549	566	intraperitoneally	T082	C0442120
28072457	585	599	postnatal days	T079	C0443281
28072457	617	621	IL-β	T116,T129	C0021753
28072457	646	659	postnatal day	T079	C0443281
28072457	664	677	Hematological	T091	C0018943
28072457	704	726	peritoneal macrophages	T025	C0206190
28072457	732	738	plasma	T031	C0032105
28072457	743	756	cerebrospinal	T169	C0007807
28072457	757	762	IL-1β	T116,T129	C0021753
28072457	763	769	levels	T080	C0441889
28072457	793	806	postnatal day	T079	C0443281
28072457	811	824	EtOH exposure	UnknownType	C0814017
28072457	832	843	adolescence	T079	C0001578
28072457	858	881	normal body temperature	T033	C0231262
28072457	923	930	febrile	T184	C0015967
28072457	931	939	response	T032	C0871261
28072457	960	963	LPS	T109	C0023810
28072457	994	1003	postnatal	T079	C0443281
28072457	1039	1046	febrile	T184	C0015967
28072457	1047	1055	response	T032	C0871261
28072457	1073	1086	postnatal day	T079	C0443281
28072457	1093	1105	EtOH-exposed	UnknownType	C0814017
28072457	1106	1113	animals	T015	C0034721
28072457	1119	1126	febrile	T184	C0015967
28072457	1127	1135	response	T032	C0871261
28072457	1156	1179	intracerebroventricular	T082	C0595818
28072457	1180	1185	IL-1β	T116,T129	C0021753
28072457	1218	1225	animals	T015	C0034721
28072457	1240	1250	binge-like	T055	C0556346
28072457	1251	1264	EtOH exposure	UnknownType	C0814017
28072457	1272	1283	adolescence	T079	C0001578
28072457	1285	1305	Acute oral treatment	T169	C1527415
28072457	1311	1315	EtOH	T109,T121	C0001962
28072457	1330	1333	LPS	T109	C0023810
28072457	1334	1348	administration	T061	C1533734
28072457	1367	1374	febrile	T184	C0015967
28072457	1375	1383	response	T032	C0871261
28072457	1404	1407	LPS	T109	C0023810
28072457	1409	1419	Binge-like	T055	C0556346
28072457	1420	1433	EtOH exposure	UnknownType	C0814017
28072457	1441	1452	adolescence	T079	C0001578
28072457	1467	1480	hematological	T091	C0018943
28072457	1509	1518	viability	T043	C0007620
28072457	1522	1544	peritoneal macrophages	T025	C0206190
28072457	1546	1556	Binge-like	T055	C0556346
28072457	1557	1570	EtOH exposure	UnknownType	C0814017
28072457	1585	1591	plasma	T031	C0032105
28072457	1592	1597	IL-1β	T116,T129	C0021753
28072457	1598	1604	levels	T080	C0441889
28072457	1621	1640	cerebrospinal fluid	T031	C0007806
28072457	1641	1647	levels	T080	C0441889
28072457	1656	1664	cytokine	T116,T129	C0079189
28072457	1693	1703	binge-like	T055	C0556346
28072457	1704	1717	EtOH exposure	UnknownType	C0814017
28072457	1725	1736	adolescence	T079	C0001578
28072457	1759	1781	central nervous system	T022	C3714787
28072457	1802	1809	febrile	T184	C0015967
28072457	1810	1818	response	T032	C0871261
28072457	1850	1859	cessation	T052	C1880019
28072457	1863	1876	EtOH exposure	UnknownType	C0814017
28072457	1936	1939	LPS	T109	C0023810
28072457	1942	1947	IL-1β	T116,T129	C0021753